 |
 |
|
 |
|
|
|
|
Management
Committee |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mr.Alok Ghosh, |
Executive Vice President - Global Dosage Form Manufacturing & Quality Assurance
|
|
|
|
|
|
| Dr
Desh Bandhu Gupta, Chairman |
|
|
An honorary doctor of philosophy with a master's degree in chemistry, Dr. Gupta started his career teaching chemistry at Birla Institute of Science and Technology, Pilani, Rajashthan. Since 1968, when he founded the company, Dr Gupta has steered Lupin towards the forefront of India pharmaceuticals.
|
|
|
In recent years, he has spearheaded the restructuring of Lupin's operations, and the research and innovation programs in new drug research and novel drug delivery systems. |
|
Top
|
|
|
Dr Kamal K Sharma, Managing Director |
|
|
Kamal K Sharma is a graduate in chemical engineering from the Indian institute of Technology
(IIT), Kanpur, with a post-graduate diploma in industrial management from Jamnalal Bajaj Institute of management Studies,
Mumbai, and a Ph.D in economics from
IIT, Mumbai. He has also completed an advanced management program from Harvard Business School,
Boston.
|
|
|
In a career spanning more
than three decades, Dr. Sharma has
held a range of senior management
positions managing projects,
corporate development and general
management in the pharmaceuticals
and chemicals industries. |
|
Top
|
|
| Satish
Khanna, Group President, API |
|
|
A graduate in chemical engineering, Satish Khanna has a background of 25 years in leading companies including Mitsu Industries, Tata Chemicals and Union Carbide. He has built Lupin's API business and secured the company's position among top manufacturers, globally.
|
|
|
Top
|
|
|
Vinita Gupta Sharma, President, Americas and Europe |
|
|
A graduate in pharmacy from the University of Mumbai and MBA from J L Kellog Graduate School of Management,
Vinita Gupta Sharma heads the advanced market business of the company. She has been instrumental in Lupin's foray in the advanced markets of the US and Europe and in cementing alliances with global majors.
|
|
|
Top
|
|
| Himadri Sen, President, Pharma research and regulatory affairs |
|
|
A Master of Sciences in Pharmacy from University of Manchester, U.K., Himadri Sen is spearheading Lupin's drive for new drug delivery systems and ANDA and patent fillings. In a career spanning over three decades, Mr.Sen has worked with leading Indian and global pharmaceutical companies in the areas of pharma research, technology development and transfer and plant supported activities.
|
|
|
He is also credited with the development and dossier submissions of
INDs, NDAs and ANDAs for advanced markets such as USA and EC.He has also developed and commercialized 60 OCRS including one product licensing to the parent MNC. He has several patents and research papers to bear testimony to his technical achievements. |
|
Top
|
|
| Rajan Dutta, President, Human Resources |
|
|
Mr. Rajan Dutta is the President – Human Resources Development, located at Corporate Office, Mumbai. He is an Economic (Honours) Graduate with MBA in HR from Punjab University. He is a Post Graduate in Training and Development from ISTD,
Delhi as well as PG in Human
Resources. He possesses rich
|
|
experience of over 22 years having
worked with organization like Vam
Organics, Xerox, RPG Enterprises and
Idea Cellular Limited.
He has joined from Bharti Airtel, where he was Chief HR & Business Excellence. Rajan will lead the HR & Admin function and will facilitate the organization to be an industry leader in people initiatives. His aim will be to ensure that Lupin becomes “The Employer of Choice” in this competitive environment.
|
|
Top
|
|
|
|
|
Shakti Chakraborty, President, IRF |
|
|
A graduate in commerce, Shakti Chakraborty heads the India region business for finished products and has driven Lupin's entry in the lifestyle
segment
|
|
|
Top
|
|
| |
|
Nilesh Gupta, President – Advanced Markets |
|
|
He is a chemical engineer from the University Department of Chemical Technology
(UDCT), Mumbai, and a graduate with honors from Wharton School, University of Pennsylvania, USA, specializing in healthcare, strategic management and finance. Nilesh Gupta is responsible for driving product identification
|
|
|
for the advanced markets and
drug delivery systems and for bringing these
products to market.
Nilesh is also responsible for identifying in-licensing and out-licensing opportunities.
|
|
Top
|
|
| |
| Mr. Indrajit Banerjee, President, Finance & Planning |
|
|
A Chartered Accountant, Indrajit
Banerjee has a rich background of
over 25 years in leading
organisations like Alcam Aluminium
Ltd, one of the world’s largest
aluminium company, and Lucent
Technologies, a major player in the
business of telecommunications.
|
|
|
He is currently heading the Finance,
Planning and Information Technology
functions in the Company.
|
|
Top
|
|
| | | | |
